GlassScriptPhysician profile
Mayelin Gonzalez
NPI 1215407671
$4,623.95
in general payments reported to CMS, 2019-2025
37 companies · $1,284 in 2025
The $1,284 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $314 · 2023: $873 · 2024: $2,153 · 2025: $1,284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,173 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,172.62 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $542.49 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $446.07 | 2022-2025 | Jardiance |
| Lilly USA, LLC | $344.12 | 2024-2025 | Zepbound, Jardiance, Mounjaro |
| Abbvie INC. | $268.34 | 2024-2025 | |
| Medical Device Business Services, INC. | $258.14 | 2024 | Stratafix |
| Novartis Pharmaceuticals Corporation | $244.87 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $243.58 | 2022-2025 | Farxiga, Fasenra, Breztri |
| Merck Sharp & Dohme LLC | $214.69 | 2022-2025 | Verquvo, Gardasil 9, Capvaxive |
| Glaxosmithkline, LLC. | $194.57 | 2024-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $168.19 | 2024-2025 | |
| Amgen INC. | $152.82 | 2022-2025 | Repatha, Repatha, Otezla |
| Lundbeck LLC | $143.91 | 2023-2024 | Rexulti |
| Medtronic, INC. | $142.87 | 2023-2024 | Reveal Linq, Cobalt Dr Mri Surescan |
| Exact Sciences Corporation | $134.85 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $100.99 | 2023-2024 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $91.51 | 2023-2025 | Valtoco |
| Boston Scientific Corporation | $86.82 | 2022-2025 | General - Pain Management, Varithena Administration Pack |
| Emd Serono, INC. | $82.18 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $76.48 | 2023-2024 | |
| Chiesi USA, INC. | $70.79 | 2022-2024 | Kengreal |
| Merz Pharmaceuticals, LLC | $68.64 | 2025 | Xeomin, Inbrija, Ampyra |
| Regeneron Healthcare Solutions, INC. | $56.67 | 2023-2024 | Evkeeza |
| Dynavax Technologies Corporation | $51.88 | 2025 | Heplisav-B |
| Janssen Pharmaceuticals, INC | $51.23 | 2024 | Xarelto, Spravato |
| Atricure, INC. | $50.47 | 2023 | |
| Renalytix Ai, INC. | $49.30 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Lexicon Pharmaceuticals, INC. | $47.17 | 2023-2024 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.87 | 2022-2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $33.50 | 2023-2024 | Eliquis |
| Corcept Therapeutics | $24.94 | 2025 | Korlym |
| Ucb, INC. | $22.00 | 2024 | Rystiggo |
| Surmodics, INC. | $21.59 | 2023 | Pounce Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Angiodynamics, INC. | $20.88 | 2024 | Auryon Laser System 100-120 Vac |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.60 | 2024 | Xifaxan |
| Si-Bone, INC. | $20.53 | 2024 | |
| Shield Therapeutics INC | $19.35 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $14.05 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayelin Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.